Most Read Articles
Pank Jit Sin, 13 May 2020
A trial vaccine for the prevention of COVID-19 is underway with the first US participants being dosed in the Phase 1/2 clinical trial. Known as the BNT162 vaccine programme, the trials are a collaboration between Pfizer Inc. and BioNTech SE, and is part of a global development programme with Germany and the US taking the lead in having the first cohorts to be vaccinated. Germany started the study 1 week earlier. 
Jairia Dela Cruz, 18 Dec 2020
Rinsing with mouthwash that contains povidone-iodine (PI) or cetylpyridinium chloride (CPC) helps reduce SARS-CoV-2 levels in the saliva of COVID-19 patients, with the effect persisting for up to 6 hours, as shown in a study from Singapore.

Social distancing slows spread of common respiratory diseases in children

09 Dec 2020

Social distancing and other lockdown interventions effectively reduce the spread of common respiratory viral diseases and decrease the need for hospitalization among children, a Finland study has shown.

The authors used hospital patient information and the Finnish national infectious disease register for this study to assess the immediate effects of national lockdown orders due to COVID-19 on paediatric emergency room (ER) visits and respiratory tract infections in hospitals and nationwide in Finland.

All patients visiting the paediatric ER in two hospital (Kuopio University Hospital and Mikkeli Central Hospital), covering one-fifth of the Finnish children population, 4 weeks before and 4 weeks after the start of the nationwide lockdown on 16 March 2020 were included.

In addition, the authors assessed nationwide weekly numbers of influenza (A + B) and respiratory syncytial virus (RSV) in children from the infectious disease register from 2015 to 2020.

The rate of daily median paediatric ER visits in both hospitals significantly decreased during the nationwide lockdown compared with the study period before the lockdown (Mikkeli: 19 vs 7; p<0.001; Kuopio: 9 vs 2.5; p<0.001).

The present influenza season was shorter at 8 weeks from peak to no cases, and the weekly rate of new cases decreased faster than the previous four influenza seasons (previously 15–20 weeks from peak to no cases). RSV also saw a similar reduction in cases.

Of note, no paediatric cases of COVID-19 were detected in the two hospitals during the study period.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pank Jit Sin, 13 May 2020
A trial vaccine for the prevention of COVID-19 is underway with the first US participants being dosed in the Phase 1/2 clinical trial. Known as the BNT162 vaccine programme, the trials are a collaboration between Pfizer Inc. and BioNTech SE, and is part of a global development programme with Germany and the US taking the lead in having the first cohorts to be vaccinated. Germany started the study 1 week earlier. 
Jairia Dela Cruz, 18 Dec 2020
Rinsing with mouthwash that contains povidone-iodine (PI) or cetylpyridinium chloride (CPC) helps reduce SARS-CoV-2 levels in the saliva of COVID-19 patients, with the effect persisting for up to 6 hours, as shown in a study from Singapore.